Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A. Thompson(The University of Melbourne), KM Steve Lo, R. Alejandro Sica, Daniel Mundt, Ryan Monahan, Dimitrios Farmakiotis(Brown University), Daniel Flora(St. Elizabeth Healthcare), Pankil Shah(Mays Cancer Center at UT Health San Antonio), Mark A. Fiala(Washington University in St. Louis), Benjamin A. Gartrell, Eyob Tadesse, Sanjay Goel(Rutgers, The State University of New Jersey), Peter Paul Yu(Connecticut Health Foundation), Vadim S. Koshkin(UCSF Helen Diller Family Comprehensive Cancer Center), Jian Campian, Anne H. Angevine, Astha Thakkar(Albert Einstein College of Medicine), Dimpy P. Shah(The University of Texas MD Anderson Cancer Center), Jeremy L. Warner(Brown University), Anthony P. Gulati(Stamford Hospital), Clara Hwang(Henry Ford Health System), Zhuoer Xie(Mayo Clinic), Jonathon W. Senefeld(University of Illinois Urbana-Champaign), Toni K. Choueiri(Harvard University), Nitin Ohri, Sanjay G. Revankar, Adam J. Olszewski(Memorial Hospital of Rhode Island), Esperanza B. Papadopoulos(Memorial Sloan Kettering Cancer Center), Sanjay Mishra(Vanderbilt University Medical Center), Arturo Loaiza‐Bonilla, Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Michael Bär, Christopher Su(Fred Hutch Cancer Center), Elizabeth Wulff‐Burchfield(University of Kansas Medical Center), Jeffrey P. Henderson(Washington University in St. Louis), Pamela Bohachek, Elizabeth Robilotti(Memorial Sloan Kettering Cancer Center), Philip E. Lammers, Orestis A. Panagiotou(Brown University), Balázs Halmos(Montefiore Medical Center), Michael J. Joyner(WinnMed), Mitrianna Streckfuss, Alice Y. Zhou, Keith Stockerl‐Goldstein(City Of Hope National Medical Center), Pamela Egan(Brown University), Amit Verma(M.J.P. Rohilkhand University), Samuel M. Rubinstein(University of North Carolina at Chapel Hill), Omar H. Butt, Hina Khan, Salvatore A. Del Prete(Stamford Hospital)
Cited by 185
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863